Twelve per cent of 6142 eyes treated for neovascular age-related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR)

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Twelve per cent of 6142 eyes treated for neovascular age-related macular degeneration (nAMD) presented with low visual outcome within 2 years. Analysis from the Swedish Macula Registry (SMR)'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Psychology

Agricultural and Biological Sciences